First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safetyTakafumi Yanagisawa, Takahiro Kimura, Taizo Uchimoto et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 7
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score’s impactTatsuo Fukushima, Haruhito Azuma, Takuya Tsujino et al.|World Journal of Urology|2025Cited by 1